Principia Biopharma Inc. 4 SEC Filings

Filed On	Filing
28 Sep 2020	Form 4: Tomasello Shawn, Director Disposed of 30,715 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Machado Patrick, Director Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: George Simeon, Director Disposed of 2,982,855 shares (Tender Offer) ($298M) · Disposed of 28,623 Warrant (Disposition to Issuer) · Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Lin Shao-Lee, Director Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Becker Daniel J., Director Disposed of 667,600 shares (Tender Offer) ($66.8M) · Disposed of 40,955 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Colowick Alan, Director Disposed of 88,679 Director Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Wolff Stefani, Chief Development Officer Gave 5,504 shares as a gift · Disposed of 13,592 shares (Tender Offer) ($1.36M) · Disposed of 238,958 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Thomas Dolca, Chief Medical Officer Disposed of 2,207 shares (Tender Offer) ($221K) · Disposed of 283,057 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Hardiman Roy C., Chief Business Officer Disposed of 119,677 shares (Tender Offer) ($12M) · Disposed of 170,553 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Chai Christopher Y, Chief Financial Officer Disposed of 7,101 shares (Tender Offer) ($710K) · Disposed of 318,395 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Goldstein David M, Chief Scientific Officer Disposed of 31,826 shares (Tender Offer) ($3.18M) · Disposed of 286,117 Employee Stock Option (right to buy) (Disposition to Issuer)
28 Sep 2020	Form 4: Babler Martin, Director Disposed of 58,557 shares (Tender Offer) ($5.86M) · Disposed of 255 Warrant (Right to Buy) (Disposition to Issuer) · Disposed of 1,047,892 Employee Stock Option (right to buy) (Disposition to Issuer)
22 Sep 2020	Form 4: Hardiman Roy C., Chief Business Officer Received 5,000 shares by exercise or conversion ($29.3K) · Sold 5,000 shares ($500K)
20 Aug 2020	Form 4: Thomas Dolca, Chief Medical Officer Received 15,000 shares by exercise or conversion ($357K) · Sold 15,000 shares ($1.5M)
20 Aug 2020	Form 4: Chai Christopher Y, Chief Financial Officer Received 7,500 shares by exercise or conversion ($22.5K) · Sold 7,500 shares ($745K)
20 Aug 2020	Form 4: Bvf Partners L P/IL, 10% owner and 9 others Acquired 2,268 Call Option (Right to Buy) (Open Market Purchase) ($81.2K)
12 Aug 2020	Form 4: Goldstein David M, Chief Scientific Officer Received 6,000 shares by exercise or conversion ($18.6K) · Sold 6,000 shares ($532K)
17 Jul 2020	Form 4: Thomas Dolca, Chief Medical Officer Received 15,000 shares by exercise or conversion ($357K) · Sold 15,000 shares ($1.2M)
02 Jul 2020	Form 4: Colowick Alan, Director Received 7,500 shares by exercise or conversion ($34.1K) · Sold 7,500 shares ($450K)
25 Jun 2020	Form 4: Babler Martin, Director Received 15,000 shares by exercise or conversion ($45K) · Sold 15,000 shares ($928K)

Comments